Andreas Hadjimichael, 10% Owner at Karyopharm Therapeutics Inc. (KPTI), sold 43,699 shares at $39.07 ($1.7M) on 2014-08-27, disclosed to the SEC on 2014-08-28.
Open-market sale of $1.7M KPTI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.50 | 20,393 | $785K | 46.3% |
| 2 | $39.09 | 1,846 | $72K | 4.3% |
| 3 | $39.07 | 21,460 | $838K | 49.4% |
| Total | $38.80 avg | 43,699 | $1.7M | 100% |
| Filing → |
| KPTI | SELL | 2018-07-23 | $4.8M | — | Filing → |
| KPTI | SELL | 2016-06-27 | $302K | — | Filing → |
| KPTI | SELL | 2016-05-23 | $298K | — | Filing → |